| 1 |
Israni AK, Zaun D, Gauntt K, et al. OPTN/SRTR 2020 annual data report: DOD[J]. Am J Transplant, 2022, 22 (Suppl 2):519-552.
|
| 2 |
Cypel M, Yeung JC, Machuca T, et al. Experience with the first 50 ex vivo lung perfusions in clinical transplantation[J]. J Thorac Cardiovasc Surg, 2012, 144(5):1200-1206.
|
| 3 |
Fischer S, Maclean AA, Liu M, et al. Dynamic changes in apoptotic and necrotic cell death correlate with severity of ischemia-reperfusion injury in lung transplantation[J]. Am J Respir Crit Care Med, 2000, 162(5): 1932-1939.
|
| 4 |
Kim H, Zamel R, Bai XH, et al. Ischemia-reperfusion induces death receptor-independent necroptosis via calpain-STAT3 activation in a lung transplant setting[J]. Am J Physiol Lung Cell Mol Physiol, 2018, 315(4): L595-L608.
|
| 5 |
Yu P, Zhang X, Liu N, et al. Pyroptosis: mechanisms and diseases[J]. Signal Transduct Target Ther, 2021, 6(1): 128.
|
| 6 |
Noda K, Tane S, Haam SJ, et al. Targeting circulating leukocytes and pyroptosis during ex vivo lung perfusion improves lung preservation[J]. Transplantation, 2017, 101(12): 2841-2849.
|
| 7 |
Yu S, Jia J, Zheng J, et al. Recent progress of ferroptosis in lung diseases[J]. Front Cell Dev Biol, 2021, 9:789517.
|
| 8 |
Xu Y, Li X, Cheng Y, et al. Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion[J]. FASEB J, 2020, 34(12): 16262-16275.
|
| 9 |
Sanada S, Kitakaze M. Ischemic preconditioning: emerging evidence, controversy, and translational trials[J]. Int J Cardiol, 2004, 97(2): 263-276.
|
| 10 |
Gourdin MJ, Bree B, De Kock M. The impact of ischaemia-reperfusion on the blood vessel[J]. Eur J Anaesthesiol, 2009, 26(7): 537-547.
|
| 11 |
Diamond JM, Christie JD. The contribution of airway and lung tissue ischemia to primary graft dysfunction[J]. Curr Opin Organ Transplant, 2010, 15(5): 552-557.
|
| 12 |
Criner RN, Clausen E, Cantu E. Primary graft dysfunction[J]. Curr Opin Organ Transplant, 2021, 26(3): 321-327.
|
| 13 |
Hashimoto K, Cypel M, Juvet S, et al. Higher M30 and high mobility group box 1 protein levels in ex vivo lung perfusate are associated with primary graft dysfunction after human lung transplantation[J]. J Heart Lung Transplant, 2018, 37(2):240-249.
|
| 14 |
Wong A, Zamel R, Yeung J, et al. Potential therapeutic targets for lung repair during human ex vivo lung perfusion[J]. Eur Respir J, 2020, 55(4): 1902222.
|
| 15 |
Chambers DC, Cherikh WS, Harhay MO, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult lung and heart-lung transplantation report-2019; focus theme: donor and recipient size match[J]. J Heart Lung Transplant, 2019, 38(10): 1042-1055.
|
| 16 |
Divithotawela C, Cypel M, Martinu T, et al. Long-term outcomes of lung transplant with ex vivo lung perfusion[J]. JAMA Surg, 2019, 154(12): 1143-1150.
|
| 17 |
Li J, Peng Q, Yang R, et al. Application of mesenchymal stem cells during machine perfusion: an emerging novel strategy for organ preservation[J]. Front Immunol, 2021, 12: 713920.
|
| 18 |
Nakajima D, Watanabe Y, Ohsumi A, et al. Mesenchymal stromal cell therapy during ex vivo lung perfusion ameliorates ischemia-reperfusion injury in lung transplantation[J]. J Heart Lung Transplant, 2019, 38(11): 1214-1223.
|
| 19 |
Miceli V, Bertani A, Chinnici CM, et al. Conditioned medium from human amnion-derived mesenchymal stromal/stem cells attenuating the effects of cold ischemia-reperfusion injury in an in vitro model using human alveolar epithelial cells[J]. Int J Mol Sci, 2021, 22(2):510.
|
| 20 |
Abreu SC, Antunes MA, Xisto DG, et al. Bone marrow, adipose, and lung tissue-derived murine mesenchymal stromal cells release different mediators and differentially affect airway and lung parenchyma in experimental asthma[J]. Stem Cells Transl Med, 2017, 6(6): 1557-1567.
|
| 21 |
Reiter J, Drummond S, Sammour I, et al. Stromal derived factor-1 mediates the lung regenerative effects of mesenchymal stem cells in a rodent model of bronchopulmonary dysplasia[J]. Respir Res, 2017, 18(1): 137.
|
| 22 |
Stone ML, Zhao Y, Robert Smith J, et al. Mesenchymal stromal cell-derived extracellular vesicles attenuate lung ischemia-reperfusion injury and enhance reconditioning of donor lungs after circulatory death[J]. Respir Res, 2017, 18(1): 212.
|
| 23 |
Ware L B, Fang X, Wang Y, et al. High prevalence of pulmonary arterial thrombi in donor lungs rejected for transplantation[J]. J Heart Lung Transplant, 2005, 24(10): 1650-1656.
|
| 24 |
Inci I, Zhai W, Arni S, et al. Fibrinolytic treatment improves the quality of lungs retrieved from non-heart-beating donors[J]. J Heart Lung Transplant, 2007, 26(10): 1054-1060.
|
| 25 |
Motoyama H, Chen F, Ohsumi A, et al. Protective effect of plasmin in marginal donor lungs in an ex vivo lung perfusion model[J]. J Heart Lung Transplant, 2013, 32(5): 505-510.
|
| 26 |
Motoyama H, Chen F, Hijiya K, et al. Plasmin administration during ex vivo lung perfusion ameliorates lung ischemia-reperfusion injury[J]. J Heart Lung Transplant, 2014, 33(10): 1093-1099.
|
| 27 |
Kumar A, Noda K, Philips B, et al. Nitrite attenuates mitochondrial impairment and vascular permeability induced by ischemia-reperfusion injury in the lung[J]. Am J Physiol Lung Cell Mol Physiol, 2020, 318(4): L580-L591.
|
| 28 |
Ghosh A, Sumi MP, Tupta B, et al. Low levels of nitric oxide promotes heme maturation into several hemeproteins and is also therapeutic[J]. Redox Biol, 2022, 56: 102478.
|
| 29 |
Schepp CP, Reutershan J. Bench-to-bedside review: adenosine receptors-promising targets in acute lung injury？[J]. Crit Care, 2008, 12(5): 226.
|
| 30 |
Emaminia A, Lapar D J, Zhao Y, et al. Adenosine A2A agonist improves lung function during ex vivo lung perfusion[J]. Ann Thorac Surg, 2011, 92(5): 1840-1846.
|
| 31 |
Stone ML, Sharma AK, Mas VR, et al. Ex Vivo perfusion with adenosine A2A receptor agonist enhances rehabilitation of murine donor lungs after circulatory death[J]. Transplantation, 2015, 99(12): 2494-2503.
|
| 32 |
Huerter ME, Sharma AK, Zhao Y, et al. Attenuation of pulmonary ischemia-reperfusion injury by adenosine A2B receptor antagonism[J]. Ann Thorac Surg, 2016, 102(2): 385-393.
|
| 33 |
Kobayashi E, Sano M. Organ preservation solution containing dissolved hydrogen gas from a hydrogen-absorbing alloy canister improves function of transplanted ischemic kidneys in miniature pigs[J]. PLoS One, 2019, 14(10): e0222863.
|
| 34 |
Yamamoto H, Aokage T, Igawa T, et al. Luminal preloading with hydrogen-rich saline ameliorates ischemia-reperfusion injury following intestinal transplantation in rats[J]. Pediatr Transplant, 2020, 24(7):e13848.
|
| 35 |
Du H, Sheng M, Wu L, et al. Hydrogen-rich saline attenuates acute kidney injury after liver transplantation via activating p53-mediated autophagy[J]. Transplantation, 2016, 100(3): 563-570.
|
| 36 |
Luo ZL, Cheng L, Ren JD, et al. Hydrogen-rich saline protects against ischemia/reperfusion injury in grafts after pancreas transplantations by reducing oxidative stress in rats[J]. Mediators Inflamm, 2015: 281985.
|
| 37 |
Noda K, Shigemura N, Tanaka Y, et al. A novel method of preserving cardiac grafts using a hydrogen-rich water bath[J]. J Heart Lung Transplant, 2013, 32(2): 241-250.
|
| 38 |
Cai J, Kang Z, Liu WW, et al. Hydrogen therapy reduces apoptosis in neonatal hypoxia-ischemia rat model[J]. Neurosci Lett, 2008, 441(2): 167-172.
|
| 39 |
Noda K, Shigemura N, Tanaka Y, et al. Hydrogen preconditioning during ex vivo lung perfusion improves the quality of lung grafts in rats[J]. Transplantation, 2014, 98(5): 499-506.
|
| 40 |
Haam S, Lee S, Paik HC, et al. The effects of hydrogen gas inhalation during ex vivo lung perfusion on donor lungs obtained after cardiac death[J]. Eur J Cardiothorac Surg, 2015, 48(4): 542-547.
|
| 41 |
Haam S, Lee JG, Paik HC, et al. Hydrogen gas inhalation during ex vivo lung perfusion of donor lungs recovered after cardiac death[J]. J Heart Lung Transplant, 2018, 37(10): 1271-1278.
|
| 42 |
Navarro MN, Gómez De Las Heras MM, Mittelbrunn M. Nicotinamide adenine dinucleotide metabolism in the immune response, autoimmunity and inflammageing[J]. Br J Pharmacol, 2022, 179(9): 1839-1856.
|
| 43 |
Ehrsam JP, Chen J, Rodriguez Cetina Biefer H, et al. Ex vivo lung perfusion with β-nicotinamide adenine dinucleotide(NAD＋) improves ischemic lung function[J]. Antioxidants (Basel), 2022, 11(5):843.
|
| 44 |
Gao W, Zhao J, Kim H, et al. α1-antitrypsin inhibits ischemia reperfusion-induced lung injury by reducing inflammatory response and cell death[J]. J Heart Lung Transplant, 2014, 33(3): 309-315.
|
| 45 |
Lin H, Chen M, Tian F, et al. α(1)-anti-trypsin improves function of porcine donor lungs during ex-vivo lung perfusion[J]. J Heart Lung Transplant, 2018, 37(5): 656-666.
|
| 46 |
Iskender I, Sakamoto J, Nakajima D, et al. Human α1-antitrypsin improves early post-transplant lung function: pre-clinical studies in a pig lung transplant model[J]. J Heart Lung Transplant, 2016, 35(7): 913-921.
|
| 47 |
Stelzner TJ, Weil JV, O′brien RF. Role of cyclic adenosine monophosphate in the induction of endothelial barrier properties[J]. J Cell Physiol, 1989, 139(1): 157-166.
|
| 48 |
Akbar S, Minor T. Significance and molecular targets of protein kinase a during cAMP-mediated protection of cold stored liver grafts[J]. Cell Mol Life Sci, 2001, 58(11): 1708-1714.
|
| 49 |
Ji H, Shen XD, Zhang Y, et al. Activation of cyclic adenosine monophosphate-dependent protein kinase a signaling prevents liver ischemia/reperfusion injury in mice[J]. Liver Transpl, 2012, 18(6): 659-670.
|
| 50 |
Chen F, Nakamura T, Fujinaga T, et al. Protective effect of a nebulized beta2-adrenoreceptor agonist in warm ischemic-reperfused rat lungs[J]. Ann Thorac Surg, 2006, 82(2): 465-471.
|
| 51 |
Sakamoto J, Chen F, Nakajima D, et al. The effect of β-2 adrenoreceptor agonist inhalation on lungs donated after cardiac death in a canine lung transplantation model[J]. J Heart Lung Transplant, 2012, 31(7): 773-779.
|
| 52 |
Kondo T, Chen F, Ohsumi A, et al. β2-adrenoreceptor agonist inhalation during ex vivo lung perfusion attenuates lung injury[J]. Ann Thorac Surg, 2015, 100(2): 480-486.
|
| 53 |
Ghaidan H, Stenlo M, Niroomand A, et al. Reduction of primary graft dysfunction using cytokine adsorption during organ preservation and after lung transplantation[J]. Nat Commun, 2022, 13(1): 4173.
|
| 54 |
Niroomand A, Hirdman G, Pierre L, et al. Proteomic changes to immune and inflammatory processes underlie lung preservation using ex vivo cytokine adsorption[J]. Front Cardiovasc Med, 2023, 10: 1274444.
|
| 55 |
Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116(2): 281-297.
|
| 56 |
Broderick JA, Zamore PD. MicroRNA therapeutics[J]. Gene therapy, 2011, 18(12): 1104-1110.
|
| 57 |
Jia P, Teng J, Zou J, et al. miR-21 contributes to xenon-conferred amelioration of renal ischemia-reperfusion injury in mice[J]. Anesthesiology, 2013, 119(3): 621-630.
|
| 58 |
Li XQ, Lv HW, Wang ZL, et al. MiR-27a ameliorates inflammatory damage to the blood-spinal cord barrier after spinal cord ischemia: reperfusion injury in rats by downregulating TICAM-2 of the TLR4 signaling pathway[J]. J Neuroinflammation, 2015, 12: 25.
|
| 59 |
Pan Z, Sun X, Ren J, et al. miR-1 exacerbates cardiac ischemia-reperfusion injury in mouse models[J]. PLoS One, 2012, 7(11): e50515.
|
| 60 |
Elgharably H, Okamoto T, Ayyat KS, et al. Human lungs airway epithelium upregulate microRNA-17 and microRNA-548b in response to cold ischemia and ex vivo reperfusion[J]. Transplantation, 2020, 104(9): 1842-1852.
|
| 61 |
Lohser J, Slinger P. Lung injury after one-lung ventilation: a review of the pathophysiologic mechanisms affecting the ventilated and the collapsed lung[J]. Anesth Analg, 2015, 121(2): 302-318.
|
| 62 |
Niikawa H, Okamoto T, Ayyat KS, et al. The protective effect of prone lung position on ischemia-reperfusion injury and lung function in an ex vivo porcine lung model[J]. J Thorac Cardiovasc Surg, 2019, 157(1): 425-433.
|
| 63 |
Ordies S, Frick AE, Claes S, et al. Prone positioning during ex vivo lung perfusion influences regional edema accumulation[J]. J Surg Res, 2019, 239: 300-308.
|
| 64 |
Niikawa H, Okamoto T, Ayyat KS, et al. Successful lung transplantation after acellular ex vivo lung perfusion with prone positioning[J]. Ann Thorac Surg, 2020, 110(4): e285-e287.
|